No profile data available.
MiniMed Group, Inc. (MMED) is a listed company, based in Northridge, United States, with about 8,000 full-time employees.
It reported revenue of $3.10 billion for fiscal year 2026, up 14.3% from fiscal year 2025, and net income of -$333.00 million. In Q1 2027 (the quarter ended July 31, 2026) revenue was $843.00 million, up 16.6% from a year before. Its market capitalization was $5.55 billion as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended April 30, 2026; market data as of October 9, 2026.
MiniMed Group, Inc. operates as a medical technology company that develops, manufactures, and markets medical equipment for the management of diabetes. The company offers technologies including insulin delivery devices, such as insulin pumps and pens, continuous glucose monitors, other consumables, supplies, and related software and services.
MiniMed reported $3.10 billion in revenue for fiscal year 2026, up 14.3% from $2.72 billion in fiscal year 2025. In Q1 2027 revenue was $843.00 million.
$5.55 billion as of October 9, 2026.